Ignite Creation Date:
2025-12-24 @ 12:14 PM
Ignite Modification Date:
2026-01-31 @ 8:56 PM
Study NCT ID:
NCT04213261
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-01
First Post:
2019-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
Sponsor:
Castle Creek Biosciences, LLC.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FI-EB-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None